Based upon this line of reasoning, we asked whether administering the anti-RhoB Ig might shut down antibody secretion in a preclinical mouse model of autoimmune disease, where autoantibody production serves as a pathogenic driver, as well as in the context of an immune response to a model antigen. This evidence concerns the gene RHOB and autoimmune disease.